1. Ceftriaxone compared with sodium penicillin g for treatment of severe leptospirosis.
- Author
-
Panaphut T, Domrongkitchaiporn S, Vibhagool A, Thinkamrop B, and Susaengrat W
- Subjects
- Adult, Female, Humans, Male, Middle Aged, Prospective Studies, Thailand, Treatment Outcome, Ceftriaxone therapeutic use, Cephalosporins therapeutic use, Leptospirosis drug therapy, Penicillin G therapeutic use, Penicillins therapeutic use
- Abstract
A prospective, open-label, randomized trial at Khon Kaen Hospital (Thailand) was conducted from July 2000 through December 2001 to compare the clinical efficacies of ceftriaxone and sodium penicillin G for the treatment of severe leptospirosis. A total of 173 patients with severe leptospirosis were randomly assigned to be treated with either intravenous ceftriaxone (1 g daily for 7 days; n=87) or intravenous sodium penicillin G (1.5 million U every 6 h for 7 days; n=86). The primary outcome was time to fever resolution. Survival analysis demonstrated that the median duration of fever was 3 days for both groups. Ten patients (5 in each group) died of leptospirosis infection. There were no statistically significant differences in the duration of organ dysfunction. Ceftriaxone and sodium penicillin G were equally effective for the treatment of severe leptospirosis. Once-daily administration and the extended spectrum of ceftriaxone against bacteria provide additional benefits over intravenous penicillin.
- Published
- 2003
- Full Text
- View/download PDF